N. M. Juhan

Porcine circovirus type 2 (PCV2)-infection and re-inoculation with homologous or heterologous strains: virological, serological, pathological and clinical effects in growing pigs

Tanja Opriessnig, John Prickett, Darin Madson et al. · Veterinary Research · 2010 · 66 citations · Full text

The open reading frame 3 (ORF3) of porcine circovirus type 2 (PCV2) is dispensable for virus infection but evidence of reduced pathogenicity is limited in pigs infected by an ORF3-null PCV2 mutant

N. M. Juhan, Tanya LeRoith, Tanja Opriessnig · Virus Research · 2009 · 56 citations

Reduced Pathogenicity, Molecular Virology, Orf3-null Pcv2 Mutant +8

Difference in severity of porcine circovirus type two-induced pathological lesions between Landrace and Pietrain pigs1

Tanja Opriessnig, A. R. Patterson, D. M. Madson et al. · Journal of Animal Science · 2009 · 51 citations

Pietrain Pigs1, Pathogenesis, Immunology +11

Replacement of the Replication Factors of Porcine Circovirus (PCV) Type 2 with Those of PCV Type 1 Greatly Enhances Viral Replication <i>I</i> <i>n</i> <i>V</i> <i>itro</i>

Nathan M. Beach, N. M. Juhan, Laura Córdoba · Journal of Virology · 2010 · 28 citations · Full text

Viral Replication, Viral Polymerase Structure, Viral Polymerase Mechanism +17

A genetically engineered chimeric vaccine against porcine circovirus type 2 (PCV2) is genetically stable in vitro and in vivo

J. Gillespie, N. M. Juhan, Jennifer A. DiCristina et al. · Vaccine · 2008 · 27 citations

Vaccination, Vaccine Development, Immunology +5